The long-term goal of our work is to understand biochemical mechanisms underlying sperm motility and fertility. In a recent study we showed that tyrosine phosphorylation of a 55-kDa protein varied in direct proportion to motility. Tyrosine phosphorylation of the protein was low in immotile compared to motile epididymal sperm. Inhibition or stimulation of motility by high calcium levels or cAMP, respectively, results in a corresponding decrease or increase in tyrosine phosphorylation of the 55-kDa protein. Here we report purification and identification of this motility-associated protein. Soluble extracts from bovine caudal epididymal sperm were subjected to DEAE-cellulose, Affi-Gel blue, and cellulose phosphate chromatography. Tyrosine phosphate immunoreactive fractions contained glycogen synthase kinase-3 (GSK-3) activity, suggesting a possible correspondence between these proteins. This suggestion was verified by Western blot analyses following one-dimensional and two-dimensional gel electrophoresis of the purified protein using monoclonal and affinity-purified polyclonal antibodies against the catalytic amino-terminus and carboxy-terminus regions of GSK-3. Further confirmation of the identity of these proteins came from Western blot analysis using antibodies specific to the tyrosine phosphorylated GSK-3. Using this antibody, we also showed that GSK-3 tyrosine phosphorylation was high in motile compared to immotile sperm. Immunocytochemistry revealed that GSK-3 is present in the flagellum and the anterior portion of the sperm head. These data suggest that GSK-3, regulated by phosphorylation, could be a key element underlying motility initiation in the epididymis and regulation of mature sperm function.
INTRODUCTION
Sperm motility and fertilization involve changes in protein phosphorylation, which is a balance between the action of protein kinases and phosphatases. Sperm contain a specific isoform of protein phosphatase 1 (PP1␥2) and glycogen synthase kinase-3 (GSK-3) [1, 2] . The PP1␥2 and GSK-3 activities are two-to sixfold higher in immotile caput compared to motile caudal epididymal sperm. Sperm PP1␥2 catalytic activity is regulated by its interaction with an inhibitor [1] that resembles inhibitor I2 found in somatic cells [1] . The inactive PP1␥2-inhibitor complex is activated by phosphorylation of this I2-like inhibitor by GSK-3. High GSK-3 activity results in high PP1␥2 activity, which in turn, is responsible for the lack of motility in immature caput epididymal sperm. Inhibition of PP1␥2 by okadaic 1 This research was supported by funds from Kent State University and NIH Grants HD36408. acid and calyculin leads to motility induction and stimulation in caput and caudal epididymal sperm, respectively [1] . These data suggest that a decrease in sperm PP1␥2 and GSK-3 activities is likely a key event in motility development in the epididymis.
Glycogen synthase kinase-3 has important functions in cellular signal transduction [3] . One of the functions of GSK-3 is activation of PP1 [4] . This is accomplished through phosphorylation of I2 on a threonine residue resulting in the dissociation of the PP1-I2 complex. Since this early discovery of the role of GSK-3 in glycogen metabolism, several new roles for GSK-3 in cell function have emerged [3] . Two isoforms of GSK-3, ␣ and ␤, are found in somatic cells. Activity of GSK-3 is regulated by tyrosine and serine/threonine phosphorylation. Tyrosine phosphorylation increases GSK-3 catalytic activity [5] . Serine/threonine phosphorylation is mediated by phosphatidyl inositol kinase-3 (PI3-kinase) and protein kinase B (PKB) [6] [7] [8] . The PI3-kinase, activated by cell adhesion, growth factor, and insulin [6, 9] , in turn activates PKB, which results in phosphorylation and inactivation of GSK-3 [6-8, 10, 11] . There are two notable aspects of GSK-3 action and regulation: 1) unlike other protein kinases, GSK-3 prefers prephosphorylated substrates-those phosphorylated by PKA or casein kinase II-and 2) while most protein kinases are activated during cellular activation, a constitutively active GSK-3 is inactivated during a cellular response.
We have previously shown that sperm contain GSK-3 [1, 2] . A decline in sperm GSK-3 activity is associated with motility development [1, 2] . In addition, we have recently shown that tyrosine phosphorylation of a 55-kDa protein [12] is associated with motility. An increase or decrease in motility causes a corresponding increase or decrease in tyrosine phosphorylation of the soluble 55-kDa protein. In this report we show that the 55-kDa tyrosine phosphorylated motility associated protein is GSK-3␣ and that GSK-3 is present in the flagellum consistent with its role in sperm motility.
MATERIALS AND METHODS

Materials
Okadaic acid, calyculin A, isobutyl-methylxanthine (IBMX), and 8-bromo-cyclic-AMP were from CalBiochem (La Jolla, CA). Centricon filters for concentration of column eluates were from Millipore Corp. (Bedford, MA) . Instead of providing a compreshensive list here, the sources of the antibodies, special chemicals, and products are indicated when their use is first mentioned in Materials and Methods. All chemicals in buffer preparations and solvents, the highest purity available, were from Sigma Chemical Co. (St. Louis, MO).
FIG. 1.
Western blot analysis of caudal sperm extracts fractionated through DEAE, Affi-Gel blue, and cellulose phosphate columns. A) Caudal sperm 100 000 ϫ g extract (20 ml) was passed through a DEAE column (10 ml) pre-equilibrated with homogenization buffer supplemented with proteolytic inhibitors. The column was washed with 20 ml of buffer. This was followed by elution with 20 ml each of buffer supplemented with 100 mM NaCl and 400 mM NaCl. Twenty-five-microliter aliquots of the column fractions were subjected to SDS gel electrophoresis followed by Western blot analysis with 4G10 antibody. B) The DEAE flowthrough fraction and the column wash was concentrated to 5 ml with Centricon-30 filter and loaded on an Affi-Gel blue column (10 ml) and eluted with 0-1 M sodium chloride linear salt gradient (80 ml). Fractions (ϳ5 ml each) were collected and tested for phosphotyrosine immunoreactivity. C) Fractions 4-10 (ϳ35 ml) from the Affi-Gel blue column were concentrated to 5 ml and loaded on a cellulose phosphate column and eluted with 10 ml each of homogenization buffer containing 50, 100, 200, and 400 mM NaCl. The fractions were tested for phosphotyrosine immunoreactivity.
Sperm Extracts
Testes of mature bulls with tunica intact were obtained from a local slaughterhouse. Bovine caudal and caput epididymal spermatozoa were isolated and washed twice as previously reported [1, 13] . Sperm pellets usually derived from a suspension of 10 9 sperm/ml, after the second wash, were suspended in homogenization buffer (10 mM Tris pH 7.2, 1 mM EDTA, and 1 mM EGTA) and sonicated with three 5-sec bursts of a Biosonic II (Bronwell Scientific, Rochester, NY) sonicator at maximum setting. In some cases the homogenization buffer was supplemented with 0.1 mM sodium orthovanadate to inhibit tyrosine phosphatase activity. The sperm sonicate was centrifuged at 16 000 ϫ g for 15 min and the supernatants spun at 100 000 ϫ g for 1 h. The 100 000 ϫ g supernatants are the soluble sperm extracts used in column chromatography or Western blot analysis.
Western Blot Analysis
Sperm extracts prepared as described above (usually 50 g) or eluates from columns (described below) were separated by SDS-gel electrophoresis through 12% polyacrylamide slab gels. After electrophoresis, proteins were electrophoretically transferred to Immobilon-P, PVDF membrane (Millipore Corp.). Nonspecific protein binding sites on the filter were blocked with 5% nonfat dry milk in Tris- buffered saline (TBS; 25 mM Tris-HCl [pH 7.4], 150 mM NaCl). The blots were washed twice for 15 min with TBS containing 0.1% Tween 20 and then incubated with antibodies. The antibodies (dilution) used were: 4G10 (1:1000), mouse monoclonal antibody against phosphotyrosine (a generous gift from Dr. Brian Druker, Oregon Health Sciences University, Portland, OR; the properties and characteristics of this monoclonal antibody are reported elsewhere [14] [15] [16] ), mouse monoclonal antibody against the catalytic domain of GSK-3 (1:1000) (Upstate Biotechnology, Lake Placid, NY) (1:1000), mouse monoclonal antibody against tyrosine phosphorylated GSK-3 (Upstate Biotechnology), and a rabbit polyclonal antibody against the carboxy-terminus domain of GSK-3␣ (1:5000). This latter antibody was produced commercially (Zymed Inc., South San Francisco, CA) with a synthetic polypeptide with the amino acid sequence WQSTDATPTLTNSS corresponding to the carboxy-terminus of GSK-3. The properties of this antibody in immunoprecipitation and Western blot have been reported [17] . After washing (twice for 10 min each), the blots were incubated with anti-mouse or anti-rabbit second antibody conjugated to horseradish peroxidase (Amersham, Piscataway, NJ) for 1 h followed by washing (twice for 15 min each, and four times for 5 min each) and developed with an ECL chemiluminescence kit (Amersham).
GSK-3 Activity
Activity of GSK-3 was measured by the ability of the enzyme to activate the PP1-I2 complex in the presence of Mg-ATP. Radiolabeled phosphorylase a was used as a substrate for measurement of PP1. Methods for preparation of this substrate and procedures for the measurement of GSK-3 activity by the PP1I activation assay are reported [1, 2] . Briefly, sperm extracts or column eluates were incubated at 30ЊC with or without ATP and PP1I (a complex of PP1 and inhibitor I2) for 5 min followed by addition of phosphorylase a. The reaction was terminated with 200 l 10% trichloroacetic acid, and the supernatants were analyzed for 32 PO 4 released from phosphorylase a.
Purification of the 55-kDa Tyrosine Phosphorylated Protein
Caudal sperm extracts (100 000 ϫ g supernatants), prepared as described above, were subjected to DEAE-cellulose (D52, diethyl aminoethyl cellulose; Whatman International), Affi-Gel blue (Blue Sepharose CL 6B; BioRad, Hercules, CA), and cellulose phosphate (P11 cellulose phosphate, Whatman International) chromatography. The column matrices were washed and prepared according to the manufacturer's instructions and resuspended in homogenization buffer. The columns (1.7 ϫ 13 cm), 10 ml total volume of the matrix, were packed and washed with 100 ml of homogenization buffer buffer before use. After protein loading the columns were washed with 20 ml of homogenization buffer. The columns were eluted either in a batchwise manner with increasing NaCl amounts in homogenization buffer (10 ml each) or a linear gradient of NaCl (80 ml in the case of Affi-Gel blue, and 200 ml for cellulose phosphate). Column eluates were assessed for GSK-3 activity and tyrosine phosphate immunoreactivity with 4G10 monoclonal antibodies.
Immunocytochemistry
Sperm were fixed in 4% formaldehyde in 0.1 M sodium phosphate and then attached to poly-L-lysine coated coverslips. They were permeabilized in methanol:acetone (Ϫ20ЊC), incubated for 1 h in a blocking solution containing 5% BSA and 5% normal goat serum in TBS at room temperature (RT), 2 h with primary antibody (anti-GSK-3 prepared against the catalytic domain [1:25], UBI) at 37ЊC, and 1 h at RT with goat anti-mouse fluorescein isothiocyanate conjugate secondary antibody (Jackson Laboratories, West Grove, PA). Sperm were examined by fluorescence and phase-contrast microscopy.
RESULTS
Purification of the 55-kDa Tyrosine Phosphorylated Motility-Associated Protein
Soluble bovine epididymal sperm extracts contain a single tyrosine-phosphorylated protein at 55 kDa [12] . Tyrosine phosphorylation of this protein varies in direct proportion to motility-that is, the protein in motile caudal sperm has a higher tyrosine phosphate content than in immotile caput epididymal sperm [12] . Furthermore, inhibition of caudal sperm motility leads to reduced tyrosine phosphorylation whereas stimulation of motility results in increased tyrosine phosphorylation of the 55-kDa protein [12] . We attempted purification of the 55-kDa tyrosine phosphorylated protein in order to determine its identity. Soluble 100K supernatant (30 mg total protein) was prepared from 25 ml of twice-washed caudal epididymal sperm suspension (1.3 ϫ 10 9 /ml) as described in Materials and Methods.
The soluble sperm extract was first fractionated through a DEAE column. The flowthrough fraction and fractions eluted with buffer containing 100 mM and 400 mM sodium chloride were collected. The 55-kDa tyrosine phosphorylated protein was detected only in the flowthrough fraction (Fig. 1A) . The DEAE-cellulose flowthrough fraction was concentrated and passed through an Affi-Gel blue column. The column was washed with loading buffer and eluted with a linear salt gradient (0-2 M). The unabsorbed and eluted protein fractions were analyzed for tyrosine phosphate immunoreactivity. The flowthrough fraction had no phosphotyrosine immunoreactivity. Fractions 4-10 of the Affi-Gel blue eluate contained the 55-kDa tyrosine phosphorylated protein (Fig. 1B) . The fractions containing the tyrosine-phosphorylated protein were pooled, concentrated, and loaded on a cellulose phosphate column. The column was eluted stepwise with increasing salt concentrations-50 mM, 100 mM, 200 mM, and 400 mM of NaCl. The tyrosine-phosphorylated protein was present in the 100 mM NaCl fraction (Fig. 1C) .
Western Blot Analyses Showing That the 55-kDa Tyrosine-Phosphorylated Protein Is GSK-3␣
Our goal was to purify the tyrosine-phosphorylated protein to homogeneity to determine its identity by peptide microsequencing. However, at this stage of purification a serendipitous observation raised the possibility that the tyrosine-phosphorylated protein could be GSK-3, a PP1-activating enzyme. We have previously shown that PP1, the inactive PP1-inhbitor complex, and the PP1 activating enzyme GSK-3 are all present in sperm-soluble extracts [1] . Because we were also interested in purifying the components of the PP1 system, we measured GSK-3 activity and GSK-3-activatable PP1 activity in the column fractions. We found that fractions containing the 55-kDa tyrosine-phosphorylated protein also contained GSK-3 activity. Data in Figure 2A show the GSK-3 activity measurements in the Affi-Gel blue fractions. The fractions with enzyme activity also showed tyrosine phosphate immunoreactivity (Fig.  2C) . We next determined if coelution of the tyrosine-phosphorylated protein and GSK-3 also occurs during the cellulose phosphate step. Elution of the cellulose phosphate column with a stepwise increase in sodium concentration described under (Fig. 1C ) was unsuited for a clear separation of GSK-3. Small amounts of the enzyme were carried over to the successive salt fractions giving a broad elution peak for the enzyme. We therefore used a salt gradient for elution. Activity measurements of GSK-3 in these fractions are shown in Figure 2B . The protein concentration in the fractions was too low for use in Western blot analysis. The fractions containing GSK-3 activity (fractions 5-11) were pooled and concentrated and shown to contain phosphotyrosine immunoreactivity (Fig. 2C, lane 4) . Figure 2C shows tyrosine phosphate immunoreactivity in sperm extracts during the three stages of its purification. These observations taken together with the fact that GSK-3 is known to be tyrosine phosphorylated in somatic cells, led us to suspect that the 55-kDa tyrosine phosphorylated sperm protein could be tyrosine phosphorylated GSK-3. To examine this possibility we used Western blot analysis following onedimensional and two-dimensional gel electrophoresis of the partially purified tyrosine-phosphorylated protein from the cellulose phosphate column. For this analysis we used four different antibodies: 1) the monoclonal antibody to phosphotyrosine, 4G10; 2) a monoclonal antibody against the catalytic domain of GSK-3 [GSK-3(cat)Ab]; 3) a monoclonal antibody against tyrosine-phosphorylated GSK- 3 FIG. 3 . Western blot analysis of purified tyrosine phosphorylated protein. Partially purified tyrosine-phosphorylated protein (5 g each) in four lanes (A-D) was subject to acrylamide gel electrophoresis followed by Western blot analysis. Lane A was probed with the pY antibody 4G10, lane B with the GSK-3 catalytic domain antibody, lane C with antibody specific to tyrosinephosphorylated GSK-3, and lane D with a polyclonal antibody against the carboxyterminus of GSK-3␣. E, F) Purified tyrosine-phosphorylated protein (5 g) was subjected to either one-dimensional (right side of blot) or two-dimensional electrophoresis. In the first dimension, isoelectric focusing was performed over a pH range of 3.0-10.0. The gel was transferred to Immobilon-P and analyzed by Western blot with 4G10 (E) or GSK-3 catalytic domain antibody (F). The arrow indicates that the identical spot stained by both antibodies.
[(pY)GSK-3Ab]; and 4) an affinity-purified polyclonal antibody against the unique carboxy-terminus of GSK-3␣ . Western blot analysis of the partially purified 55-kDa protein preparation probed with these four antibodies is shown in Figure 3 . The same protein at 55 kDa is recognized by the phosphotyrosine antibody 4G10 (Fig.  3A) , GSK-3(cat)Ab (Fig. 3B) , (pY)GSK-3Ab (Fig. 3C) , and GSK-3␣Ab (Fig. 3D) . Further analysis of the relationship between these proteins came from two-dimensional gel electrophoresis followed by Western blot analysis. Data in Figure 3 , E and F, show the correspondence (arrowhead) between the protein bands recognized tyrosine phosphate antibody and GSK-3 immunoreactivity. These experiments show that the migration and purification patterns of the 55-kDa tyrosine-phosphorylated motility protein and GSK-3␣ are identical and suggest these proteins are one and the same.
Demonstration That GSK-3␣ Is Tyrosine Phosphorylated in Proportion to Motility
Our earlier study [12] showing that the 55-kDa protein was tyrosine phosphorylated in proportion to motility was performed with the pY antibody 4G10, a monoclonal antibody that recognizes all tyrosine-phosphorylated proteins. Protein purification studies described above show that this sperm tyrosine-phosphorylated protein is GSK-3␣. In the light of this conclusion, our next objective was to show that tyrosine phosphorylation of GSK-3␣ increased in direct proportion to motility. Demonstration of changes in tyrosine phosphorylation of GSK-3 would not only confirm our earlier results obtained with the pY antibody 4G10 [12] , but also further strengthen our conclusion that the 55-kDa motility-associated tyrosine-phosphorylated protein is GSK-3␣. These studies were undertaken using the antibody specific to tyrosine-phosphorylated GSK-3 (pY)GSK-3Ab (see Fig. 3C ).
Western blot analysis of caput and caudal sperm extracts probed with (pY)GSK-3Ab show that GSK-3 is indeed tyrosine phosphorylated to a much greater extent in motile caudal compared to immotile caput epididymal sperm (Fig.  4A) . Next we determined whether motility induction in caput epididymal sperm would be accompanied by an increase in tyrosine phosphorylation of GSK-3. Extracts were prepared from caput epididymal sperm treated with the motility stimulants IBMX (0.5 mM), 8-Br-cAMP (1 mM), okadaic acid (10 M), and calyculin (50 nM). The ability of these compounds to induce motility in caput epididymal sperm is well established [1, 18] . Extracts from untreated sperm and sperm treated with the motility-inhibiting peptide sHT-31 [19] GSK-3 is about twofold higher in lanes 2-5 compared to control values in lanes 1 and 6. Figure 4C is a Coomassie blue stain of this blot showing that equal protein was loaded in these lanes.
Subcellular Localization of GSK-3
We next determined the localization of GSK-3 within sperm by fluorescence immunocytochemistry (Fig. 5) . The monoclonal antibody against the catalytic domain of GSK-3 was used. Immunostaining is observed in the posterior portion of the sperm head and along the entire length of the flagellum. Comparatively little or no staining was observed in the equatorial and the anterior segment of the head. No staining was observed in sperm stained with identical dilutions of normal rabbit serum (not shown). This immunolocalization is consistent with Western blot analysis of sperm extracts which showed that GSK-3 is present entirely in the soluble fraction.
DISCUSSION
Protein phosphorylation and dephosphorylation are universal biochemical mechanisms used in the regulation of protein function. Changes in serine/threonine phosphorylation following changes in the levels of cAMP and activation of PKA has been proposed to be a key mechanism regulating sperm function-in the initiation and regulation of sperm motility and in the regulation of sperm capacitation and acrosome reaction [20] [21] [22] . More recently, numerous reports have documented that in addition to serine/ threonine phosphorylation, protein tyrosine phosphorylation is also involved in the regulation of sperm function. Changes in tyrosine phosphorylation of a number of proteins were shown to accompany the onset of sperm capacitation and acrosome reaction [23, 24] . We recently showed that tyrosine phosphorylation of a soluble 55-kDa sperm protein varies in direct proportion to motility [12] . The purpose of this work was to determine the identity of this tyrosine-phosphorylated protein. The protein was partially purified through three steps of column chromatography.
Because GSK-3 activity coeluted with the 55-kDa protein during purification we suspected that these two proteins could be identical. Western blot analyses of the partially purified protein fraction using a panel of four different antibodies strongly suggest that the 55-kDa protein is GSK-3. The catalytic domain of GSK-3(KQLVRGEPNVSY-ICSRYY) is conserved in species as diverse as plants, yeast, and mammals. The bold tyrosine residue is phosphorylated in vivo. Monoclonal antibodies against this catalytic domain that can recognize both the phosphorylated and nonphosphorylated forms of GSK-3 and a phosphoprotein-specific antibody that recognizes only the tyrosinephosphorylated form of GSK-3 are now commercially available. These two GSK-3 antibodies and the pY antibody 4G10 react to the same protein in Western blot analysis of purified tyrosine-phosphorylated sperm protein (Fig. 3 , A and C). Using antibodies against the carboxy-terminus domain of GSK-3␣ we further demonstrated that the tyrosinephosphorylated 55-kDa is indeed GSK-3␣ (Fig. 3D) . The specificity and properties of this GSK-3␣ antibody in immunoprecipitation and Western blot analysis is well documented [17] . The identity between the 55-kDa tyrosine phosphorylated protein and GSK-3␣ was further verified by Western blot analysis following two-dimensional gel electrophoresis (Fig. 3, E and F) .
The 55-kDa protein was detected and changes in its phosphorylation was first documented [12] using the monoclonal antibody 4G10-an antibody that reacts to all phosphotyrosine-containing proteins. We have now further verified this observation using phosphotyrosine-specific antibodies against GSK-3. The GSK-3␣ protein is phosphorylated to a much greater extent in motile caudal compared to immotile caput epididymal sperm (Fig. 4A) . Furthermore increases in GKS-3 tyrosine phosphorylation also accompany motility initiation in caput epididymal sperm (Fig.  4B) . These data not only verify our observations made with 4G10 antibodies [12] but also provide strong support to our conclusion that the 55-kDa protein whose tyrosine content varies in direct proportion to motility is GSK-3␣.
The questions of great interest are 1) how is GSK-3 activity modified by phosphorylation, and 2) what are the enzymes that phosphorylate GSK-3? We have previously shown that GSK-3 activity in sperm extracts is lower in motile caudal compared to immotile caput epididymal sperm [1] . We have further confirmed this observation by enzyme activity measurements of GSK-3 immunoprecipitated from sperm extracts (data not shown). This enzyme activity data considered together with the fact that GSK-3 is tyrosine phosphorylated at a much lower level in caput compared to caudal sperm suggest that tyrosine phosphorylation is one of the mechanisms involved in the regulation of GSK-3 activity in sperm. Because GSK-3 activity is low in caudal epididymal sperm [1] , and yet tyrosine is phosphorylated to a greater extent in caudal compared to caput epididymal sperm, it follows that tyrosine phosphorylation of GSK-3 should result in lowered catalytic activity. This situation would be the opposite of that observed in somatic cells where tyrosine phosphorylation has been shown to increase rather than decrease GSK-3 activity [5] . However, it is quite possible that serine/threonine phosphorylation, in addition to tyrosine phosphorylation, may be involved in sperm GSK-3 activity regulation. Indeed preliminary data, using antibodies specific to serine-phosphorylated GSK-3, shows that GSK-3 is phosphorylated both at tyrosine and serine residues. Studies on how tyrosine and serine phosphorylation of GSK-3 alters its catalytic activity and identification of the enzymes involved in this phosphorylation are in progress.
The next question concerns the protein targets of GSK-3 action and how changes in GSK-3 activity caused by its phosphorylation affect motility. We propose that one of the targets of GSK-3 is phosphorylation and inactivation of an I2-like inhibitor of PP1␥2. Inactivation of PP1␥2 inhibitor would lead to increased protein phosphatase activity and lowered motility [1] . However, we cannot rule out additional roles for GSK-3 in sperm motility regulation. It is possible that a constitutively active GSK-3 phosphorylates and inhibits the action of key protein substrates involved in sperm metabolism and kinetic activity. Inactivation of GSK-3 by phosphorylation relieves this inhibition and permits motility. Remarkably, we have found that, in addition to mammalian sperm, GSK-3 is present in sperm from a wide variety of species including horseshoe crab, sea urchin, frog, and turkey (manuscript in preparation). This evolutionary conservation of the enzyme in sperm, along with data showing its localization in the flagellum, and its motility-associated changes in tyrosine phosphorylation suggest an important role for GSK-3 in regulating sperm function. Studies to determine how GSK-3 phosphorylation is regulated and studies to identify the protein targets of sperm GSK-3 are being actively pursued in our laboratory.
